Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2017 049 525.5 |
96 | EP file number | EAKZ | 17 80 5772.5 |
86 | WO file number | WAKZ | PCT/CN2017/086269 |
97 | EP publication number | EPN | 3466940 |
87 | WO publication number | WPN | 2017206827 |
54 | Designation/title | TI | KRISTALLFORM VON NATRIUM-GLUCOSE-COTRANSPORTERS-2-INHIBITOR |
51 | IPC main class | ICM (ICMV) | C07D 309/10 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07D 207/16 (2006.01), A61K 31/401 (2006.01), A61K 31/351 (2006.01), A61P 3/04 (2006.01), A61P 3/10 (2006.01), A61P 5/50 (2006.01) |
22 | DE application date | DAT | May 27, 2017 |
96 | EP application date | EAT | May 27, 2017 |
86 | WO application date | WAT | May 27, 2017 |
43 | Date of first publication | OT | Dec 7, 2017 |
| Date of publication of grant | PET | Nov 17, 2021 |
71/73 | Applicant/owner | INH | Beijing Huizhiheng Biotechnology Co., Ltd., Beijing, CN; Huisheng Biopharmaceutical Co., Ltd., Meihekou, Jilin, CN |
72 | Inventor | IN | SHU, Chutian, Jinan Shandong 250101, CN; WANG, Zhenhua, Jinan Shandong 250101, CN |
| Address for service | | VALIPAT, 1050 Brussels, BE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| CN 201610369705 May 28, 2016
|
| Due date | FT FG | May 31, 2026 Annual fee for the 10th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003466940A1 Searchable text:
EP000003466940A1 Original document:
EP000003466940B1 Searchable text:
EP000003466940B1 Original document:
WO002017206827 Searchable text:
WO002017206827 |
43 | Date of first publication | EVT | Dec 7, 2017 |
| Date of the first transfer into DPMAregister | EREGT | Apr 10, 2019 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 24, 2025 (Show all update days)(Hide all update days)- Apr 24, 2025
- Due date: changed
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 17.11.2021: new
- Procedures: Procedure relating to EP application, EPO publication of mention of grant , 17.11.2021: deleted
- Oct 18, 2024
- Address for service: changed
- Oct 10, 2024
- St.36: changed (technical change)
- Jun 7, 2024; Apr 30, 2024; Mar 7, 2024; Feb 1, 2024; May 10, 2023; Nov 10, 2022; Oct 6, 2022; Apr 21, 2022; Nov 29, 2021; Oct 28, 2021; Aug 15, 2019
- Historical data not available for this/these date(s)
- Apr 10, 2019
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 7)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Jan 31, 2024 |
| Issue number | HN | 10 |
| Year | PJ | 2024 |
| Publication date | VT | Mar 7, 2024 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Beijing Huizhiheng Biotechnology Co., Ltd., Beijing, CN; Huisheng Biopharmaceutical Co., Ltd., Meihekou, Jilin, CN |
71/73 | Previous applicant/owner | INHF | Beijing Huizhiheng Biotechnology Co., Ltd., Beijing, CN, Ji Lin Hui Sheng Bio-pharmaceutical Co., Ltd., Jilin, CN |
| Date of update of the procedure | REGT | Mar 7, 2024 |